Goldman Sachs Said Biogen's (BIIB) BG-12 Acceptance Should Alliaate Concerns

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. OSIS
9. BJ
10. ANF

Go back to Goldman Sachs Said Biogen's (BIIB) BG-12 Acceptance Should Alliaate Concerns
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 217.59 +3.24 (1.51%)
Previous Close $214.35    52 Week High $333.65 
Open $217.76    52 Week Low $223.02 
Day High $219.12    P/E 27.86 
Day Low $215.00    EPS $7.81 
Volume 319,134